Search research articles
Contact Us
Filters
Showing results (101-110 of 117) with videos related to
Page
of 12
Sort By:
Blood Advances
|
February 10, 2025
Single-cell dynamics of breakthrough toxicities after anakinra prophylaxis for axicabtagene ciloleucel in lymphoma
Matthew J Frigault, Ning Yao, Trisha R Berger, et al.
Journal for Immunotherapy of Cancer
|
December 18, 2020
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events
Marcela V Maus, Sara Alexander, Michael R Bishop, et al.
Neuro-Oncology
|
July 4, 2023
Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells
Philipp Karschnia, Isabel C Arrillaga-Romany, April Eichler, et al.
Blood Advances
|
November 4, 2020
Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma
Marcelo C Pasquini, Zhen-Huan Hu, Kevin Curran, et al.
Blood Advances
|
January 10, 2020
PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation
Matthew J Frigault, Philippe Armand, Robert A Redd, et al.
Blood
|
March 18, 2021
A rapid genotyping panel for detection of primary central nervous system lymphoma
Mihir Gupta, Evan J Burns, Nicholas Z Georgantas, et al.
Leukemia
|
January 27, 2025
International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma
Luciano J Costa, Rahul Banerjee, Hira Mian, et al.
Blood
|
May 23, 2024
Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies
Matthew J Frigault, Charlotte E Graham, Trisha R Berger, et al.
Transplantation and Cellular Therapy
|
October 9, 2025
Erratum to <Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome><[Transplant Cell Ther. 2023 Jul;29(7):438.e1-438.e16. Epub 2023 Mar 9]>
Melissa R Hines, Tristan E Knight, Kevin O McNerney, et al.
Transplantation and Cellular Therapy
|
March 11, 2023
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome
Melissa R Hines, Tristan E Knight, Kevin O McNerney, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 117) with videos related to
Sort By:
Page
of 12
Blood Advances
|
February 10, 2025
Single-cell dynamics of breakthrough toxicities after anakinra prophylaxis for axicabtagene ciloleucel in lymphoma
Matthew J Frigault, Ning Yao, Trisha R Berger, et al.
Journal for Immunotherapy of Cancer
|
December 18, 2020
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events
Marcela V Maus, Sara Alexander, Michael R Bishop, et al.
Neuro-Oncology
|
July 4, 2023
Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells
Philipp Karschnia, Isabel C Arrillaga-Romany, April Eichler, et al.
Blood Advances
|
November 4, 2020
Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma
Marcelo C Pasquini, Zhen-Huan Hu, Kevin Curran, et al.
Blood Advances
|
January 10, 2020
PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation
Matthew J Frigault, Philippe Armand, Robert A Redd, et al.
Blood
|
March 18, 2021
A rapid genotyping panel for detection of primary central nervous system lymphoma
Mihir Gupta, Evan J Burns, Nicholas Z Georgantas, et al.
Leukemia
|
January 27, 2025
International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma
Luciano J Costa, Rahul Banerjee, Hira Mian, et al.
Blood
|
May 23, 2024
Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies
Matthew J Frigault, Charlotte E Graham, Trisha R Berger, et al.
Transplantation and Cellular Therapy
|
October 9, 2025
Erratum to <Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome><[Transplant Cell Ther. 2023 Jul;29(7):438.e1-438.e16. Epub 2023 Mar 9]>
Melissa R Hines, Tristan E Knight, Kevin O McNerney, et al.
Transplantation and Cellular Therapy
|
March 11, 2023
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome
Melissa R Hines, Tristan E Knight, Kevin O McNerney, et al.
Page
of 12